Butterfly Network, Inc.
HealthcareNYSE:BFLY · New York Stock Exchange
-$0.14 today
Vol 5.34M · Avg 4.78M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
-39.3%
avg 2010.3%
ROIC
-36.9%
avg -64.5%
ROA
-26.0%
avg -42.0%
Analysis
ROA is currently the strongest return metric at -26.0% versus its period average of -42.0%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Joseph DeVivo | Chief Executive Officer, President & Chairman of the Board | $2.09M | — | 59 | $8.03M | 3.07% |
Steven Cashman | Executive Vice President & Chief Business Officer | $935,776.00 | — | 49 | $1.63M | 0.62% |
John N. Doherty | Executive VP & CFO | $770,420.00 | — | 61 | $1.51M | 0.58% |
Victor Ku | Senior Vice President & Chief Technology Officer | $705,216.00 | — | 61 | $1.10M | 0.42% |
Jonathan Rothberg | Founder & Director | $57,500.00 | — | 62 | $0.00 | <0.01% |
Nicholas Caezza | VP & Deputy General Counsel & Corporate Secretary | — | — | 35 | $310,307.00 | 0.12% |
Kate Driscoll | Vice President of Compliance, Quality & Regulatory | — | — | — | — | — |
Megan Carlson | Chief Accounting Officer & Senior VP of Finance & Accounting | — | — | 42 | $507,209.00 | 0.19% |
Mercedes Kelemen | Vice President of Human Resources | — | — | — | — | — |
Nick Caezza | Vice President & Deputy General Counsel | — | — | — | $310,307.00 | 0.12% |
John S. Soto | Senior Vice President of International | — | — | 62 | $1.51M | 0.58% |
John Martin | Chief Medical Officer Emeritus | — | — | 67 | $1.51M | 0.58% |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
10
$12.15M
Sells
45
$27.71M
Net Sentiment
$15.55M
Net selling
Most Active
ROTHBERG JONATHAN M
25 transactions
1–10 of 55
Analysis
Insiders reported 10 buys worth $12.15M and 45 sells worth $27.71M over the last 12 months. That adds up to net selling of $15.55M. ROTHBERG JONATHAN M was the most active insider with 25 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A0 analysts |
| Revenue | N/A | N/A | +38.6% | +14.7% (8yr)1 analysts |
| Net Income | N/A | N/A | N/A | N/A1 analysts |
| EBIT | N/A | N/A | N/A | N/A1 analysts |
Analysis
Recent growth has been strongest in Revenue at +38.6% over three years. Forward estimates point to Revenue at +14.7% (8yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Day One Biopharmaceuticals, Inc.
DAWN
$2.22B
AMN Healthcare Services, Inc.
NYSE:AMN
$1.19B
Astria Therapeutics, Inc.
ATXS
$718.13M
SI-BONE, Inc.
NASDAQ:SIBN
$683.87M
Evolent Health, Inc.
NYSE:EVH
$539.91M
Fulgent Genetics, Inc.
NASDAQ:FLGT
$530.52M
Valneva SE
NASDAQ:VALN
$507.78M
Arvinas, Inc.
NASDAQ:ARVN
$489.07M
Pacific Biosciences of California, Inc.
NASDAQ:PACB
$406.89M
Orthofix Medical Inc.
NASDAQ:OFIX
$376.33M
Who manages BFLY?
Butterfly Network, Inc. (BFLY) lists 12 active executives. The top listed executive is John N. Doherty, Executive VP & CFO.
Are BFLY insiders buying or selling?
Recent insider activity shows net selling of $18.33M.
Explore More
Continue the stock analysis
Jump to another research area for this company.